Pliant Therapeutics (PLRX)
Develops integrin-targeted medicines and delivery technologies after its fibrosis-program reset.
$1.13
vs last close−0.01 (−0.88%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 77.68% | 48.10M shares | |
|---|---|---|---|
| 88 holders · as of Jun 30, 2026 | |||
| Insiders | 8.33% | 5.16M shares | |
| 8 holders · as of Jan 22, 2026 | |||
| Strategic holders | 7.75% | 4.80M shares | |
| 1 holder · as of Jan 25, 2024 | |||
| Other | 6.24% | 3.86M shares | |
| remainder | |||
61.92M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
88 holders · 48.10M shares · 9 new positions · 29 increased · 23 reduced · 14 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Tang Capital Management LLC | 6.14M | 9.92% | −1.9K | Aug 14, 2026 |
| Adar1 Capital Management, LLC | 5.51M | 8.90% | +2.92M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 2.44M | 3.94% | +97.3K | Aug 13, 2026 |
| Acadian Asset Management LLC | 2.42M | 3.90% | 0 | Aug 13, 2026 |
| Two Sigma Investments, LP | 2.26M | 3.65% | +9.7K | Aug 14, 2026 |
| Citadel Advisors LLC | 2.14M | 3.46% | −1.08M | Sep 2, 2026 |
| Renaissance Technologies LLC | 2.05M | 3.31% | +197.0K | Aug 13, 2026 |
| Monaco Asset Management Sam | 1.94M | 3.13% | 0 | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Tang Capital Management, LLCincl. Tang Capital Partners International, LP, Tang Capital Partners Iii, Inc +4 more | 9.60% | 5.86M | 13D | Mar 10, 2025 |
| ADAR1 Capital Management, LLC | 8.90% | 5.51M | 13G | Aug 14, 2026 |
| Jeremy C. Greenincl. Redmile Group, LLC | 5.30% | 3.20M | 13G | Nov 14, 2024 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jan 20, 2026 | Minnie Kuoofficer: Chief Operating Officer | Sale | 6,917 | $1.28 | 37,806 |
| Jan 20, 2026 | Bernard Couliedirector, officer: President and CEO | Sale | 89,375 | $1.28 | 505,601 |
| Jan 20, 2026 | Lily Cheungofficer: Chief Human Resource Officer | Sale | 7,534 | $1.28 | 44,847 |
| Jan 20, 2026 | Keith Lamont Cummingsofficer: Chief Financial Officer | Sale | 24,002 | $1.28 | 297,214 |
House and Senate disclosures
Not reported.